Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Craig Leonardi

Dermatology Saint Louis, MO Medical Doctor

NPI 1477626869 CMS profile 293579

1034 S Brentwood Blvd, Suite 600, Saint Louis, MO 63117

Open in the dashboard

General payments

$569,106

1,048 records reported · program years 2019–2024

Research payments

$11,223

Paid to them · 12 records reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,107,911 paid to institutions, not to them · program years 2019–2023

Through program year 2024, Craig Leonardi of Saint Louis, MO is reported in the CMS Open Payments database as having received $569,106 across 1,048 general payments and $11,223 in research payments paid to them. Separately, studies naming them as principal investigator received $1,107,911 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $2,363 1
2023 General $3,125 1
2022 General $47,706 222
2022 Research $26 1
2021 General $124,572 269
2021 Research $2,055 2
2020 General $150,316 195
2020 Research $2,270 6
2019 General $241,024 360
2019 Research $6,872 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Craig Leonardi
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Craig Leonardi were reported at $0. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Craig Leonardi Dermatology median Middle half National median
2019 $241,024 $454 $129–$1,240 $163
2020 $150,316 $235 $81–$756 $114
2021 $124,572 $377 $108–$1,108 $132
2022 $47,706 $514 $143–$1,391 $149
2023 $3,125 $607 $159–$1,674 $160
2024 $2,363 $751 $204–$1,903 $164
2025 $0 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Lilly USA, LLC $165,108 172 payments
  2. AbbVie, Inc. $80,794 215 payments
  3. Novartis Pharmaceuticals Corporation $76,522 121 payments
  4. UCB, Inc. $65,057 100 payments
  5. Janssen Scientific Affairs, LLC $55,239 45 payments
  6. Amgen Inc. $36,954 121 payments
  7. Eli Lilly and Company $18,694 8 payments
  8. Janssen Biotech, Inc. $17,940 80 payments
  9. Ucb SA $11,548 10 payments
  10. Boehringer Ingelheim International GmbH $9,807 7 payments
  11. Other $31,444 169 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $344,968 145 payments
  2. Consulting Fee $169,047 52 payments
  3. Travel and Lodging $24,860 69 payments
  4. Food and Beverage $19,062 764 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $6,400 3 payments
  6. Honoraria $2,800 1 payment
  7. Compensation for serving as faculty or as a speaker for a medical education program $1,400 1 payment
  8. Education $483 11 payments
  9. Grant $87 2 payments
Products named General payments · program years 2019–2024
  1. TALTZ $148,538 147 payments
  2. TREMFYA $64,264 96 payments
  3. SKYRIZI $51,034 144 payments
  4. COSENTYX Dermatology $47,832 65 payments
  5. Cimzia $45,822 80 payments
  6. Otezla Inflammation $31,445 111 payments
  7. HUMIRA $24,193 92 payments
  8. COSENTYX Immunology $23,038 56 payments
  9. SILIQ $8,474 25 payments
  10. Otezla Dermatology $8,193 6 payments
  11. Other $23,358 246 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Eli Lilly and Company $7,566 9 payments
  2. Amgen Inc. $2,500 2 payments
  3. AbbVie, Inc. $1,157 1 payment

Records

1,060 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record